Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer
2 years ago
[{"url":"https://i.ytimg.com/vi/A1kZdi4FOEI/hq720.jpg?sqp=-oaymwE2COgCEMoBSFXyq4qpAygIARUAAIhCGAFwAcABBvABAfgB1AaAAuADigIMCAAQARh_ICcoNjAP&rs=AOn4CLB7oyp6q7UdZF9nHyr8X71afIikmw","width":360,"height":202},{"url":"https://i.ytimg.com/vi/A1kZdi4FOEI/hq720.jpg?sqp=-oaymwE2CNAFEJQDSFXyq4qpAygIARUAAIhCGAFwAcABBvABAfgB1AaAAuADigIMCAAQARh_ICcoNjAP&rs=AOn4CLApsDAWvlj_O-pLNycCS2OHvZBdmw","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/A1kZdi4FOEI/mqdefault_6s.webp?du=3000&sqp=CJbVsKkG&rs=AOn4CLBwWVDPzLzZBr8RLkXpl2yFAnO0LA","width":320,"height":180}
[{"text":"The ARAMIS trial looked at the role of the drug darolutamide in treating patients with nonmetastatic, castration-"},{"text":"resistant","bold":true},{"text":" prostate\u00a0..."}]
{"name":"Video Journal of Biomedicine","id":"UCuVlT9T6SY5Cl6-Tt32N6jQ","thumbnails":[{"url":"https://yt3.ggpht.com/6Pqsiec93ij1hvePhp1dIX-hiviKSZBNSej_lIyyWzrhfr3LVLv-K_DpJ5MwDPOEJFEM_48dtA=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCuVlT9T6SY5Cl6-Tt32N6jQ"}
{"title":"Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer by Video Journal of Biomedicine 3,859 views 2 years ago 1 minute, 35 seconds","duration":"1 minute, 35 seconds"}